GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CKD Bio 063160.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

11,290

0.00%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩160.07bn

FY2016FY2025

Net income

−₩2.89bn

FY2016FY2025

Free cash flow

−₩10.96bn

FY2016FY2025

Shareholders' equity

₩127.04bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩160.07bn₩171.76bn₩160.35bn₩156.04bn₩142.24bn₩124.60bn₩137.18bn₩124.51bn₩118.19bn₩113.01bn
Research and development₩3.36bn₩3.17bn₩14.98bn₩15.43bn₩11.52bn₩9.12bn₩10.70bn₩7.88bn₩6.67bn₩5.62bn
Operating income₩3.61bn₩14.41bn−₩19.56bn−₩15.68bn−₩11.43bn₩7.61bn₩15.41bn₩7.01bn₩9.03bn₩11.62bn
Net income−₩2.89bn₩8.70bn−₩24.19bn−₩16.70bn−₩6.58bn₩6.21bn₩12.26bn₩7.96bn₩8.02bn₩9.43bn
Diluted earnings per share-563.091,696.23-4,716.35-3,256.19-1,282.111,210.142,391.051,477.231,488.391,751.72

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩299.87bn₩284.49bn₩293.79bn₩312.59bn₩298.54bn₩283.46bn₩233.35bn₩184.52bn₩179.48bn₩180.91bn
Total liabilities₩172.83bn₩153.48bn₩170.76bn₩164.79bn₩137.05bn₩114.71bn₩74.88bn₩36.86bn₩37.44bn₩45.75bn
Debt₩17.25bn₩59.91bn₩69.43bn₩80.37bn₩89.27bn₩59.20bn₩26.46bn₩4.91bn₩6.02bn₩11.03bn
Shareholders' equity₩127.04bn₩131.01bn₩123.02bn₩147.80bn₩161.49bn₩168.75bn₩158.46bn₩147.66bn₩142.05bn₩135.16bn
Shares outstanding5m5m5m5m5m5m5m5m5m5m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩4.14bn₩14.03bn−₩7.22bn−₩3.20bn−₩5.88bn₩4.82bn₩16.99bn₩15.54bn₩20.45bn₩15.50bn
Capital spending−₩6.82bn−₩4.28bn−₩10.78bn−₩6.20bn−₩20.49bn−₩61.66bn−₩47.31bn−₩16.40bn−₩9.67bn−₩10.76bn
Free cash flow−₩10.96bn₩9.75bn−₩18.00bn−₩9.40bn−₩26.37bn−₩56.83bn−₩30.32bn−₩860.7m₩10.77bn₩4.74bn
Dividends paid−₩548.6m——−₩548.6m−₩1.10bn−₩1.03bn−₩1.03bn−₩2.05bn−₩2.05bn−₩1.80bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩41.09bn₩40.70bn₩42.22bn₩34.12bn₩41.21bn₩42.52bn₩31.42bn₩43.88bn
Operating income−₩4.37bn−₩393.5m₩108.8m−₩747.9m₩2.88bn₩2.20bn₩209.2m₩2.58bn
Net income−₩5.41bn−₩2.03bn−₩1.13bn−₩2.18bn−₩480.0m₩900.2m₩1.18bn₩285.2m
Diluted earnings per share-1,053.73-395.57-220.14-424.86-93.57175.49229.9955.60
Cash from operations₩2.62bn₩771.0m−₩907.0m−₩1.47bn₩3.19bn−₩4.95bn₩221.0m₩4.16bn
Capital spending−₩3.37bn−₩3.66bn−₩2.85bn−₩973.0m−₩1.80bn−₩1.20bn−₩864.0m−₩782.0m
Free cash flow−₩750.0m−₩2.89bn−₩3.75bn−₩2.45bn₩1.39bn−₩6.15bn−₩643.0m₩3.38bn
Total assets₩293.05bn₩298.38bn₩299.87bn₩295.23bn₩292.37bn₩293.98bn₩284.49bn₩290.89bn
Debt₩44.35bn₩45.85bn₩17.25bn₩18.65bn₩57.02bn₩58.51bn₩59.91bn₩62.55bn
Shareholders' equity₩119.57bn₩125.00bn₩127.04bn₩128.67bn₩130.86bn₩131.35bn₩131.01bn₩129.87bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.9%5.1%34.4%
Operating income—-13.9%19.1%
Net income-44.3%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin5.4%-2.7%-2.3%1.6%
Net margin1.8%-5.4%-3.9%0.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-36.113.0-5.1-7.3-32.666.012.313.413.712.8
Price to sales0.70.70.80.81.53.31.10.80.91.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Dec 2024.

FY2024FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Paid in the year100.00100.00200.00190.476190.476380.952380.952333.333
  • 21-for-20 split · 27 Dec 2019

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.